Bioactive Milk Peptides and Blood Pressure

Valio Ltd

Overview

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Stage 1 Hypertension

Interventions

Milk peptides and plant sterolsDIETARY_SUPPLEMENT

PlaceboOTHER

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age 30-60 years * systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement * apparently healthy Exclusion Criteria: * antihypertensive and lipid-lowering drugs * unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension * BMI \> 32 kg/m2 * milk allergy * smoking * alcohol abuse * pregnancy, lactation * simultaneous participation in other clinical trial

Locations (1)

Valio Ltd

Helsinki, Uusimaa, Finland

Outcomes

Primary Outcomes

Blood pressure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.